Convention Name and Webcast to be held March 3, 2021 at 8:00 a.m. Japanese Time
Firm to Current on the Cowen 41st Annual Well being Care Convention on March 4, 2021
YARDLEY, Pa., Feb. 17, 2021 (GLOBE NEWSWIRE) — Optinose (NASDAQ:OPTN), a pharmaceutical firm centered on sufferers handled by ear, nostril and throat (ENT) and allergy specialists, at present introduced the Firm will report monetary outcomes for the fourth quarter 2020 and company updates, earlier than market open on Wednesday, March 3, 2021.
Firm to Host Convention Name
Members of the Firm’s management workforce will host a convention name to debate monetary outcomes and company updates. The decision is scheduled to begin at 8:00 a.m. Japanese Time on Wednesday, March 3, 2021.
To take part on the convention name, please dial (866) 916-4761 from the U.S. or +1 (409) 216-6496 from exterior the U.S. As well as, following the completion of the decision, a phone replay might be accessible till Wednesday, March 10, 2021 by dialing (855) 859-2056 from the U.S. or +1 (404) 537-3406 from exterior the U.S. and getting into convention ID #9833299. A simultaneous webcast of the decision and presentation will be accessed by visiting the Traders part of Optinose’s web site at www.optinose.com. As well as, a replay of the webcast might be obtainable on the Firm web site for 60 days following the occasion.
Cowen 41st Annual Well being Care Convention
As well as, the Firm introduced that introduced that Chief Govt Officer Peter Miller will current an organization overview and enterprise replace on the Cowen 41st Annual Well being Care Convention on Thursday, March 4, 2021, at 1:30 p.m. Japanese Time.
To take heed to a webcast of the presentation reside, please go to the Traders web page of the Optinose web site. A replay of the webcast might be obtainable for 30 days following the conclusion of the occasion.
Optinose is a worldwide specialty pharmaceutical firm centered on serving the wants of sufferers cared for by ear, nostril and throat (ENT) and allergy specialists. To study extra, please go to www.optinose.com or comply with us on Twitter and LinkedIn.
Optinose Investor Contact